Loxapine for schizophrenia

Keyphrases

• Schizophrenia 100%
• Loxapine 100%
• Confidence Interval 70%
• Relative Risk 60%
• Adverse Effects 30%
• Mental States 30%
• Fixed Effects Model 20%
• Global Effect 20%
• Placebo 20%
• Antipsychotics 20%
• Extrapyramidal Symptoms 20%
• Intramuscularly 20%
• Selection Criteria 10%
• Search Strategy 10%
• Continuous Data 10%
• Heterogeneous Data 10%
• Number-needed-to-treat 10%
• Cochrane 10%
• Dichotomous Data 10%
• Typical Antipsychotics 10%
• Atypical Antipsychotics 10%
• Quetiapine 10%
• Risperidone 10%
• Global State 10%
• Weighted Mean Difference 10%
• Intention-to-treat 10%
• Psychosis 10%
• Randomized Controlled Clinical Trial 10%
• Adverse Effect Profile 10%
• Antipsychotic Effect 10%
• Thiothixene 10%
• Haloperidol 10%
• Antipsychotic Dose 10%
• Negative Symptoms of Schizophrenia 10%
• Older Generation 10%

Neuroscience

• Dementia Praecox 100%
• Loxapine 100%
• Adverse Effect 40%
• Typical Antipsychotic 30%
• Antipsychotic 30%
• Placebo 20%
• Risperidone 10%
• Atypical Antipsychotic 10%
• Quetiapine 10%
• Negative Syndrome 10%
• Haloperidol 10%
• Thiothixene 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Loxapine 100%
• Randomized Controlled Trial 50%
• Adverse Event 40%
• Antipsychotic 40%
• Placebo 20%
• Typical Antipsychotic 20%
• Number Needed to Treat 10%
• Atypical Antipsychotics 10%
• Risperidone 10%
• Quetiapine 10%
• Negative Syndrome 10%
• Controlled Clinical Trial 10%
• 4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol 10%
• Thiothixene 10%